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Abstract
Background Identification of differentially expressed genes, i.e., genes whose transcript abundance level differs across 
different biological or physiological conditions, was indeed a challenging task. However, the inception of transcriptome 
sequencing (RNA-seq) technology revolutionized the simultaneous measurement of the transcript abundance levels for 
thousands of genes.
Objective In this paper, such next-generation sequencing (NGS) data is used to identify biomarker signatures for several of 
the most common cancer types (bladder, colon, kidney, brain, liver, lung, prostate, skin, and thyroid)
Methods Here, the problem is mapped into the comparison of optimization algorithms for selecting a set of genes that lead 
to the highest classification accuracy of a two-class classification task between healthy and tumor samples. As the opti-
mization algorithms Artificial Bee Colony (ABC), Ant Colony Optimization, Differential Evolution, and Particle Swarm 
Optimization are chosen for this experiment. A standard statistical method called DESeq2 is used to select differentially 
expressed genes before being feed to the optimization algorithms. Classification of healthy and tumor samples is done by 
support vector machine
Results Cancer-specific validation yields remarkably good results in terms of accuracy. Highest classification accuracy is 
achieved by the ABC algorithm for Brain lower grade glioma data is 99.10%. This validation is well supported by a statisti-
cal test, gene ontology enrichment analysis, and KEGG pathway enrichment analysis for each cancer biomarker signature
Conclusion The current study identified robust genes as biomarker signatures and these identified biomarkers might be 
helpful to accurately identify tumors of unknown origin
Keywords Biomarker · Machine learning tools · Messenger RNA · Optimization algorithm · Pathway analysis
Introduction
Cancer classification based on gene expression data is of 
great interest in recent years. These gene expression data 
have been widely used to differentiate cancerous tissue sam-
ples from healthy ones as well as to identify different sub-
types of cancer (Lapointe et al. 2004; Mramor et al. 2007; 
Liu et al. 2008). In this regard, the application of high-
throughput DNA sequencing technology provides an entirely 
new platform for cancer classification. Gene expression 
data generally have high dimensionality with a relatively 
small number of samples (Furey et al. 2000). Therefore, it 
becomes a challenging task to design a robust classification 
algorithm that mines informative genes with definite bio-
logical significance. In this regards, a comprehensive review 
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Available feature selection methods for high-dimensional 
data often fall into one of the following three categories: filter, 
wrapper, and embedded methods. (i) Filter methods are fast in 
operation and low in computational complexity. They assess 
the genes according to the inherent features of the expression 
data. Univariate filter methods include t-test (Olopade and 
Grushko 2001), correlation coefficient (Iyer et al. 1999), sig-
nal-to-noise ratio (Golub et al. 1999) etc. Whereas, correlation-
based feature selection (Wang et al. 2005), and Markov blanket 
filter (Han and Liu 2012) are considered to be multivariable 
filter methods; (ii) wrapper methods (Ooi and Tan 2003), 
measure the usefulness of a subset of features in the space of 
all possible feature subsets. Local minima problem is avoided 
by wrapper method as it performs a search using stochastic 
approximations that cover a large portion of the feature space; 
(iii) embedded methods, make use of the internal information 
in a classification model to perform feature selection. Classi-
fier such as support vector machine (SVM) with radial basis 
function (RBF) kernel based on recursive feature elimination 
(SVM–RBF–RFE) (Liu et al. 2011) and random forest (Kan-
daswamy et al. 2011) are an example of embedded methods.
Based on these three classes of feature selection tech-
niques, various methods have been proposed and evaluated 
for correctly identifying cancer tumors (Peng et al. 2010; 
Liu et al. 2010; Chandra and Gupta 2011). In this regard, 
gene markers like PBGD (circulatory blood) (Haas et al. 
2009), TGM4 (semen) (Wobst et al. 2011), HBD1 (vagi-
nal secretion), MMP7 (Fleming and Harbison 2010), KRT4 
(oral mucosa) (Richard et al. 2012), STATH (nasal secre-
tion) and CST6 (skin) (Juusola and Ballantyne 2007) plays 
very crucial role to identify differentially expressed genes. 
The method developed by (Zhang et al. 2012) exhibits broad 
generalization in the genes selected using 9 two-class gene 
expression datasets. In addition to this, markers like (Argani 
et al. 2001; Wang et al. 2004) are designed for the detection 
of pancreatic and colon cancers.
Despite the effort, however, these implemented techniques 
differ according to their modeling performance. Additionally, 
the informative genes selected by different feature selection 
methods are very minute overlapped. Therefore, the evaluation 
of the robustness of feature selection methods deserves more 
attention (Chopra et al. 2010). In this work, we have searched 
putative gene biomarkers from a population of the healthy and 
tumor samples. The problem is mapped into the comparison 
of optimization algorithms for selecting a set of features that 
lead to the highest classification accuracy of a two-class clas-
sification task between healthy and tumor samples. We have 
solved this optimization problem by means of Artificial Bee 
Colony (ABC) (Karaboga and Basturk 2007), Ant Colony 
Optimization (ACO) (Dorigo et al. 2006), Differential Evolu-
tion (DE) (Storn and Price 1997), and Particle Swarm Optimi-
zation (PSO) (Kennedy 2011) algorithms. These algorithms 
iteratively select a subset of differentially expressed genes 
identified by a standard statistical method called, DESeq2 
(Love et al. 2014). Classification of healthy and tumor samples 
is done using SVM (Boser et al. 1992), and genes responsible 
for the highest classification accuracy is returned as a candi-
date panel of biomarkers. In order to prevent irrelevant results 
to be included in the panel because of the intrinsic random-
ness of the method, we run our algorithm 50 times and used a 
majority voting scheme to select the final set of differentially 
expressed genes. The subset of overlapping genes responsi-
ble for highest classification accuracy is considered to be the 
optimal biomarker signature by different algorithms. For this 
analysis, next-generation-sequencing (NGS) based messenger 
RNA (mRNA) datasets of bladder, colon, kidney, brain, liver, 
lung, prostate, skin, and thyroid cancer are considered. We 
have investigated the biological role of our method selected 
genes by performing different experiments like gene ontol-
ogy (GO) enrichment analysis and KEGG pathway enrichment 
analysis. Major highlights of this paper are:
– Comparative analysis between the healthy and a tumor 
group of samples, in order to identify significantly dif-
ferentially expressed genes across nine cancer types.
– Performance check of the optimization algorithms like 
the ABC, ACO, DE, and PSO for selecting a set of genes 
that lead to the highest classification accuracy of a two-
class classification task between healthy and tumor sam-
ples.
– Variation of modeling performance among the optimi-
zation algorithms lead to the selection of the minutely 
overlapped set of genes irrespective of the datasets.
– Identified genes play a key role in diverse biological 
processes. Biological significance tests show that most 
of the identified genes are involved in key oncogenesis 
pathways.
– The identified biomarker signatures in our experi-
ments might be helpful to accurately identify tumors of 
unknown origin, as well as the proposed model itself, 
may be applied to other clinical queries.
The remainder of this article is organized as follows: in 
“Employed algorithms” section we describe a brief over-
view of the employed algorithms. The proposed method is 
described in “Proposed method” section. The dataset, pre-
processing as well as results are shown and discussed in 
“Experimental results” section. Finally, in “Conclusions” 
section we draw our conclusions.
Employed algorithms
One fundamental idea behind the proposed method is that 
of finding putative gene biomarkers by means of optimiza-
tion algorithms. In this regard, prediction provided by ABC, 
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ACO, DE, and PSO are compared. These algorithms search 
the best feature subsets or genes by iteratively improving 
their candidate solutions. All these optimization algorithms 
are randomized by nature and hence, the different algorithm 
may select different panels of genes. This randomization 
effect of the used algorithms is considered here to decrease 
the probability of returning suboptimal solutions containing 
false positives and/or false negatives. Although this proce-
dure does not ensure the absence of false positives or false 
negatives, some considerations can be done.
Artificial Bee Colony
According to ABC (Karaboga and Basturk 2007) paradigm, 
there are three kinds of honey bees named: employed bees, 
onlookers and scouts. Conventionally, both the onlookers 
and the scouts are termed as unemployed bees. Here, the 
possible solution of the optimization problem lies in the 
available position of a food source where the nectar amount 
of a food source represents the quality of fitness. The num-
ber of possible solutions in the population represents the 
number of the employed bees or the onlooker bees. Numeri-
cal functions are optimized in three stages according to the 
ABC algorithm. At first, a random initial population of size 
Ncl (food source positions) is generated. Each solution or 
food source has  number of optimization parameters. An 
employed or onlooker bee probabilistically change the pos-
sible solution in her memory for finding a new food source 
and tests the nectar amount or the possible fitness value of 
the new source i.e., the new solution. This nectar informa-
tion of the food source (solutions) and the position of the 
food sources are being shared by the employed bees with 
the onlooker bees on the dance area. If the nectar informa-
tion is higher than that of the previous one, then the bee 
memorizes the new position and forgets the old one. The 
second stage starts with the updation of onlookers where 




fitn . Here fiti denotes the fitness value of the 
i-th solution in the population. During the update process, 
a new candidate solution is firstly given by the following 
solution search equation:
where xij (or ij ) denotes the jth element of xi (or i ), and 
j is a random index, j ∈ {1, 2,… ,} . xk denotes another 
solution selected randomly from the population where 
k ∈ {1, 2,… ,ℰb} . ij represents a uniform random number 
in [− 1, 1] and ℰb corresponds to the number of employed 
bees. The update process is completed here by a greedy 
selection between xi and Zi . If the new food source has at 
least as much nectar as the old one, it replaces this latter 
in the memory. According to the algorithm, every solu-
tion of the employed bee is involved in the update process, 
(1)ij = xij +ij(xij − xkj)
while only the selected solutions have the opportunity to be 
updated by the onlookers. This is the third important stage 
which differentiates the employed bee and the onlookers. 
Moreover, an inactive solution of the scout bee refers to 
a solution that does not change over a certain number of 
generations.
The ABC and SVM are used here to select a feature of 
importance. It can effectively find potential genes that can 
be treated as biomarkers.
Ant Colony Optimization
ACO (Dorigo et al. 2006) algorithm is mainly applied to 
optimization problems, and generally consists of four main 
steps: initialization, construct ant solutions, local search, 
and global update pheromones. During the first step, all the 
parameters are initialized and pheromone variables are ini-
tialized to a value 0 . Subsequently, during the construct 
ant solutions step, each ant begins with an empty solu-
tion sp = ∅ . Moreover, a set of m ants construct the ini-
tial solution, and during the process, an ant chooses one 




∈ N(sp) ⊆ C . In this way, it upgrades its current partial 
solution. Here, N(Sp) represents a set of solution compo-
nent, defined mainly by an implemented solution construc-
tion process. In this regard, meaningfully in-feasible partial 
solutions during the construction mechanism are penalized, 
depending on the violation of the problem constraints. At 
each construction step, a probabilistic method is used to 
choose the solution component. One of the most commonly 
used by ACO is described below:
Here,  = 0 corresponds to the selection probabilities that 
is proportional to [ij] . Generally, a high heuristic solution 
component is selected whereas,  = 0 represents the phero-
mone amplification at work. Here, the local search algorithm 
step is used in a problem specific manner to improve the 
complete candidate solution further that cannot be enhanced 
by individual ant. The pheromone update is implemented 
here to make the desired solution components for the next 
iteration. Generally, a mechanism called pheromone deposit, 
and pheromone trial evaporation is used for updating the 
pheromone information. During the pheromone deposit 
operation, the level of pheromone of a chosen set of solution 
component Supd is increased. Pheromone trial evaporation 
decreases the level of pheromone deposited over time by 
the previous ants. This process is necessary to avoid a rapid 
convergence of the algorithm to a suboptimal region. The 





















 Genes & Genomics
1 3
Here, g(s) is called the evaporation function and Supd rep-
resents the set of solutions used for depositing pheromone. 
Typically, based on the pheromone update mechanism ACO 
algorithm differs. Various way of determining the Supd 
results in different pheromone update mechanism.
In the context of gene selection, an ACO algorithm has 
the ability to perform a flexible and robust search for a good 
combination of genes.
Differential Evolution
DE (Storn and Price 1997) searches for a global optimum solu-
tion in a D-dimensional real parameter space ℛD . DE is an 
evolutionary optimization tool that has a wide range of appli-
cations. Here, DE is used to encode features. As in any other 
evolutionary algorithm, population initialization in DE begins 
with a randomly initiated population of Nip vectors. Each vec-
tor often denoted as a chromosome, forms a candidate solu-
tion to the optimization problem. The i-th individual vector of 
the population at time-step (generation) t has L components 
(dimensions), chosen randomly from the set 1, 2,… ,D , where 
D is the total number of features, i.e.,
The operation of mutation is employed by DE for produc-
ing a mutant vector concerning each parent vector. Here for 
every vector in the current population, three other vectors 
are selected to perform arithmetic mutation. Actually, using 
this process mutually exclusive values are randomly gener-
ated within the range [1, L]. In other words, the L-th compo-
nent of each trial vector is generated as follows:
Here, F is a mutation factor. In order to enhance the potential 
diversity of the population, a uniform crossover has been 
applied after generating the mutant vector. Here, crossover 
rate, CR is used as a user-specified constant within the range 
[0, 1], which controls the fraction of parameter values to be 
copied from the mutant vector into the trial vector. The rest 
of the parameters of the trial vector is taken from the cor-
responding parent vector.
where
In Eq. 7, randj(0, 1) is the j-th evaluation of a uniform ran-
dom number generator with outcome ∈ [0, 1] . rand(i) is a 
(3)







(4)i(t) = [i,1(t),i,2(t),… ,i,L(t)]
(5)i,L(t + 1) = j,L(t) + F(n,L(t) −m,L(t))
(6)i(t + 1) = [i,1(t + 1),i,2(t + 1),… ,i,L(t + 1)
(7)
i,j(t + 1) =
{
i,j(t + 1), if randj(0, 1) ≤ CR, or j = rand(i)
i,j(t), if randj(0, 1) > CR, and j ≥ rand(i)
}
randomly chosen index ∈ {1, 2,… , L} , which ensures that 
i(t + 1) gets at least one parameter from i(t + 1).
During the selection process of the current population, 
the objective function value of each trial vector is com-
pared to that of its corresponding parent vector. If the new 
trial vector yields an equal or lower value of the objective 
function, then the corresponding parent vector is replaced 
in the next generation. Otherwise, the parent is retained in 
the population. Hence, the population never deteriorates, 
either get better or remains the same in fitness status. The 
next generation is represented as follows:
where f(·) is the objective function to be maximized. Finally, 
elitism kept the best vector of the current population for the 
next iteration, based on its objective function value. The 
above-mentioned processes are repeated for a given number 
of generations until stopping criteria are met.
For this experiment, the goal of DE is to find the subset 
of genes that maximizes classification accuracy with the 
help of SVM.
Particle Swarm Optimization
PSO (Kennedy and Eberhart 1995) is a simple, robust and 
effective optimization technique. According to PSO, a 
population of Npar candidate solutions (called a swarm) is 
represented as particles Pi , where i = {1, 2,… ,Npar} . The 
elements of a particle are called positions and the length 
of the particle are denoted with L. The velocity (Vi) and 
position of each particle is updated during its movement in 
the search space as following equations (Shi and Eberhart 
1998):
where t represents a time stamp of different iteration, w is 
the inertia weight ∈ [0.5, 1] , 1 and 2 are the cognitive and 
social constants. Similarly, Plbest particle represents local best 
of the current iteration, while global best particle (till the 
current iteration) is Pgbest . The PSO algorithm terminates 
after a predetermined number of iterations (Nitr).
For this experiment, a swarm is prepared by consider-
ing the Npar number of particles where each particle having 
L gene indices selected randomly from the preprocessed 
dataset of gene. The encoded swarm is used to compute the 
fitness function with the help of a SVM classifier in 5 Fold 
Cross Validation mode.
(8)i(t + 1) =
{
i(t + 1), if f (i(t + 1)) > f (i)
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Proposed method
A cohort of 4127 tumor patients are divided into nine differ-
ent tissue types is considered for this experiment. Our input 
consists of a matrix where each row corresponds a gene and 
columns are the samples. In addition, we know the class 
label of each sample. According to this input description, 
our problem reduces to that of finding a subset of signifi-
cantly differentially expressed genes, called gene markers. 
Steps of the proposed method are described below:
Differential expression analysis
In gene expression analysis, a fundamental task is the analy-
sis of read counts per gene in RNA-sequence to measure 
the systematic changes across experimental conditions. For 
this analysis, a method called DESeq2 (Love et al. 2014) 
is considered here, that measure the differential analysis of 
count data, using shrinkage estimation for dispersions and 
logarithmic fold changes. The use of DESeq2 enhances the 
quantitative analysis of comparative RNA-sequence data 
by integrating methodological advances with several novel 
features. However, DESeq2 only uses the raw counts of data 
and does not actually use normalized counts. The differential 
analysis assumes the null hypothesis that the logarithmic 
fold change between the healthy and tumor samples for a 
gene’s expression is exactly equal to zero, i.e., genes are 
not affected by treatment. Moreover, differential expression 
analysis produces a list of genes passing multiple test crite-
ria, ranked by adjusted P-value.
Optimization
In this study, we have considered a set of four optimiza-
tion methods to handle the model. Published performance 
(Karaboga et al. 2014; Dorigo et al. 2008) and the results 
for a set of benchmark problems (Abu-Mouti and El-Hawary 
2011; Dorigo and Stützle 2003; Cai et al. 2008; Eberhart and 
Shi 2001) have motivated us to select ABC, ACO, DE, and 
PSO algorithms for the optimization problems. Although 
these methods do not ensure the absence of a sub-optimal 
solution, the researcher can solve a given problem using dif-
ferent optimization methods and compare the outcomes to 
reach a final decision. Usually, all these methods converge 
to the best solution. Moreover, the results cannot be treated 
as a global optimum.
The used optimization techniques require an initial popu-
lation that is named differently. For example, in ABC, colony 
size is chosen as Ncl whereas the number of the particle 
for ACO as Npar , the initial population for DE as Nip and a 
swarm is prepared in PSO by considering the Npar number 
of particles. Index encoding is used here to prepare the ini-
tial population. For this analysis, L number of gene indices 
are selected randomly from the preprocessed differentially 
expressed genes. Here, the value of L is chosen very small in 
order to make the classifier robust. For our experiment, L is 
considered as 20. These L genes are presented as attributes 
for  number of patients. Therefore each particle, colony or 
population, is made up of a distinct dataset of size  × L . 
Here, ABC, ACO, DE, and PSO finds the best performing 
feature subsets or genes by iteratively improving their candi-
date solutions. The algorithm terminates after Nitr iterations.
Fitness computation
The objective of a fitness function is to quantify the quality 
of solution of the optimization algorithms. In fact, we are 
interested in a function that maximizes the chances of iden-
tifying differentially expressed genes among the healthy and 
tumor samples. This, in turn, can be seen as a two-class clas-
sification problem. In this regard, a SVM classifier with RBF 
kernel is used for classification. The distinct datasets of size 
 × L are passed to the SVM for computing the fitness func-
tion based on classification accuracy. Aimed at improving 
the stability of the method, we have applied tenfold cross-
validation to classification. Block diagram of the proposed 
method is presented in Fig. 1.
Optimal signature
The used optimization algorithms are randomized by nature. 
Different runs of the algorithms may select different sets of 
a gene, hence, running this algorithm once may not be a 
good idea. Therefore, we have set the number of iterations 
to be as Nitr = 50 . In order to find an optimal signature, a 
selection strategy based on majority voting is introduced 
here. According to that selection mechanism, the set of 
genes selected by an optimization algorithm after Nitr itera-
tions are represented as M = {m1,m2,… ,mitr} and mapr be 
the number of times a gene appear after 50 runs. Thereafter, 
the selected genes are sorted in decreasing order of their 
magnitude such that mapri ≥ maprj if i < j . As a result, most 
appeared gene tops the list. Finally, for increasing value of 
i ∈ [1, itr] we make a new subset of gene and classify them 
using SVM classifier. The subset of a gene responsible for 
highest classification accuracy is considered as the optimal 
signature.
Biological validation
Biological validation of the optimal biomarker signature is 
done by means of KEGG pathway enrichment analysis and 
GO enrichment analysis. For KEGG pathway enrichment 
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analysis, the overlap between the known KEGG pathways 
and constructed protein-protein interaction (PPI) networks, 
is searched to find out PPI enriched KEGG pathways. GO 
enrichment analysis is used to perform the enrichment analy-
sis on gene sets.
Experimental results
Datasets
In this work, NGS based mRNA expression datasets from 
The Cancer Genome Atlas (TCGA)1 have been chosen 
(TCGA data version 2016.01.28). Expression levels of 9 
of the most diffused cancer types (Bladder, Colon, Kidney, 
Brain, Liver, Lung, Prostate, Skin, and Thyroid) are studied 
in our experiment. TCGA exploits the illumina technology 
for sequencing and provides the expression data in the form 
of raw read count (RRC). A patient in TCGA is represented 
by a barcode-like ‘TCGA-4H-AAAU-01A-11R-A41B-07’.
Different fields of this barcode consist of a collection of 
identifiers that are specifically decoded to identify the tumor 
and healthy samples. For our convenience, we have trans-
formed the expression values into log2 scale. Table 1 sum-
marizes the datasets and provides the information on tumor 
samples. In order to eliminate the biases due to a limited 
number of healthy samples during the experiment, we have 
grouped them together regardless of the cancer type obtain-
ing a total of 465 healthy samples. Moreover, the Cancer 
Genome Atlas provides the expression level of 20,531 genes 
for the chosen cancer types, belonging to a variable number 
of samples. While dividing the datasets into training and test 
sets, it has been ensured that each of these sets had an equal 
proportion of healthy or cancerous samples.
Results
The main objective here is to find putative gene biomarkers 
from a population of a healthy and tumor samples. For this 
analysis, disease status for the 4592 (4127 tumors and 465 
healthy) individuals with gene expression data are inves-
tigated. Significant changes in gene expression profiles 
between the healthy and tumor samples are considered to 
be the underline criteria to identify differentially expressed 
genes, 𝒟ℰ . In this regards, absolute logarithmic fold change 
(FC) value > 1.5 and an adjusted p-value of < 0.05 are con-
sidered to be the underline criteria by DESeq2 to identify 
differentially expressed genes. Details of the differentially 
expressed gene counts are summarized in Table 2. The test 
result shows, DESeq2 consistently identified near-about 
9000 (minimum of 8744 for KIRC and maximum of 9987 
for PRAD dataset) differentially expressed genes independ-
ent from the cancer type.
Subsequently, during the next step of our method glob-
ally differentially expressed ( 𝒟ℰg ) genes are identified from 
Fig. 1  Block diagram of the proposed workflow
Table 1  Details of TCGA data used in the experiments
Each tumor class is coupled with 465 samples of healthy class
Disease Code Tumor samples
Bladder urothelial carcinoma BLCA 408
Colon adenocarcinoma COAD 287
Kidney renal clear cell carcinoma KIRC 534
Brain lower grade glioma LGG 530
Liver hepatocellular carcinoma LIHC 373
Lung adenocarcinoma LUAD 517
Prostate adenocarcinoma PRAD 498
Skin cutaneous melanoma SKCM 471
Thyroid carcinoma THCA 509
Total 4127
1 http://gdac.broad insti tute.org/.
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these initial filtered 𝒟ℰ genes. For that, ABC, ACO, DE, 
and PSO optimization algorithms in conjunction with an 
SVM classifier are used to enforce the evidence of the pres-
ence/absence of cancer. In particular, we have evaluated the 
individual contribution of each of our chosen optimization 
algorithm in the gene selection process. During the com-
parison, we have used K-fold cross-validation (K = 10) by 
fixing the SVM parameters. The choice of K must take into 
account the bias-variance tradeoff because large optimistic 
bias leads to over-fitting. Increasing K, reduces the bias but 
might increase variance to the point of uselessness and too 
small K, like twofold cross-validation, also has a large vari-
ance. 10-fold is usually considered a good compromise and 
sufficient to minimize any over-fitting issue. Therefore, in 
our analysis 10-fold cross-validation is chosen. In Online 
Appendix Table A1, 6 of the most frequently used classifi-
cation measures (namely: Accuracy, Precision, Sensitivity, 
Specificity, F-measure, and Matthews correlation coefficient 
(MCC) ) are reported for each cancer type. Results indicate 
that all the used optimization methods achieve a satisfac-
tory classification accuracy. Moreover, ABC has an average 
performance better than the other methods in all the tested 
datasets.
Optimal gene signature
Different run of the optimization algorithms is likely to 
produce a slightly different panel of genes. In order to cre-
ate a stable and reliable panel in which the probability of 
false positives or false negatives is minimized, we run the 
optimization algorithms 50 times. In fact, our experiment 
shows that running optimization algorithm 50 times, return 
heavily overlapping sets of genes. Thereafter, majority vot-
ing schema is used to select stable group. Although this 
procedure does not ensure the absence of false positives or 
false negatives, some considerations can be done. Hence, 
we have sorted the overlapping set genes in decreasing order 
of their appearance. Thus, most appeared gene by a selec-
tion process tops the list. The same set of a list is prepared 
for all optimization algorithms belonging to different can-
cer types (see Table S1 in the supplementary material for 
details). Next, for an increasing number of genes in that 
list, a new subset is prepared (taking a minimum of 2 genes 
and maximum of mitr genes) and classified using a SVM 
classifier. The classification accuracy of the different sub-
set of genes is reported in Table S1 in the supplementary. 
According to that result, the subset of a gene responsible for 
highest classification accuracy is considered as the optimal 
gene signature corresponding to the different optimization 
algorithm. For eg., in BLCA data for ABC algorithm, the 
subset of genes KAT2B, SGCE, SLC35B3, ACO1, ACOT1, 
ANKHD1, APBA1, ARHGAP31, ARMCX1, BBS7, C3orf38, 
and C9orf82 are responsible for highest classification accu-
racy, hence considered as the optimal biomarkers (classifica-
tion accuracy 91.40% ). The final list of our method selected 
optimal biomarkers for different algorithms and datasets can 
be found in Table 3. Logarithmic fold change (FC), adjusted 
p-value, and appearance ( mapr ) information of the optimal 
genes are reported in Table S2 of the supplementary and all 
these information signifies the importance of optimal genes.
We have further investigated the relationships among the 
identified overlapping sets of a gene by different optimi-
zation algorithms. Results reported in Fig. A1 of Online 
Appendix, confirm that informative genes selected by dif-
ferent optimization algorithms are minutely overlapped 
irrespective of used datasets. Variation of modeling per-
formance among the optimization algorithms could be the 
major cause of these results. Hence for this experiment, best 
performing subset of genes from all four optimization algo-
rithms are considered to be the optimal biomarkers in differ-
ent cancer data. Selected gene counts at different processing 
steps are depicted in Table 2.
Statistical analysis
As the optimal signatures are predicted by different optimi-
zation algorithms, i.e., ABC, ACO, DE, and PSO. Hence, 
the  measurement of significant contributions of these 
Table 2  Selection of the 
number of genes at different 




Optimization method selected genes Optimal signature genes
ABC ACO DE PSO ABC ACO DE PSO
BLCA 9343 944 931 942 942 12 7 15 11
COAD 9376 936 930 917 934 8 15 12 8
KIRC 8744 941 919 920 931 13 15 8 11
LGG 9585 932 948 942 942 9 8 10 7
LIHC 9488 936 949 931 947 17 7 13 15
LUAD 9825 947 951 941 946 13 12 13 12
PRAD 9987 952 942 959 947 14 14 18 12
SKCM 9354 946 954 921 943 11 11 15 11
THCA 9116 929 949 912 938 12 10 8 19
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algorithms is important to our research. For that analysis, a 
non-parametric statistical significance test called the Fried-
man test (Friedman 1937) at 5% significance level is cho-
sen. According to that test outcome in Table 4, the sum of 
ranks given by Friedman test corresponding to ABC, ACO, 
DE, and PSO are 9, 26, 19, and 36 respectively. Since ABC 
achieve the lowest rank among the used algorithms hence, 
it has an advantage with statistical test ranking. The ranks 
reveal average Chi-square value and a corresponding p-value 
of 25.93 and 0.00000986, respectively. Therefore, it indi-
cates the acceptance of an alternative hypothesis, i.e., among 
the used optimization algorithms, ABC comes out to be the 
superior.
Details of the parameters used in this experiment are 
summarized in Table 5. Best practices from the literature 
are considered for choosing most parameters while problem 
specific experimental evaluation is also considered in some 
cases. The RBF kernel used by SVM is controlled by means 
of two parameters:  , and the trade-off between training error 
and margin  . We set  = 0.5 and  = 2.0.
Biological significance
The biological significance of the optimal signature genes 
are examined in terms of GO enrichment analysis to identify 
the different biological process that is associated with those 
genes and KEGG pathway enrichment analysis to find out 
the associated pathways of the informative genes.
Gene ontology analysis
GO enrichment analysis of the optimal biomarkers in dif-
ferent cancer data are performed via GO consortium (Ash-
burner et al. 2000). Here in Table 6, significant functionally 
enriched GO Biological processes related to the genes of 
our panel are reported, while that for Celular component and 
Molecular function are mentioned in Table A2 and A3 in 
Online Appendix, respectively. Results shows GO:0005737 
Cytoplasm and GO:0044444 Cytoplasmic part are the most 
stressed cellular components. This activity is more likely 
due to the part of all the contents of a cell excluding the 
plasma membrane and nucleus. Other GO terms including 
GO:0071840 Cellular component organization or biogen-
esis involve in a process that results in the biosynthesis of 
constituent macromolecules, assembly, arrangement of 
constituent parts, or disassembly of a cellular component, 
GO:0051130 Positive regulation of cellular component 
organization involved in the formation, arrangement of con-
stituent parts, or disassembly of cell structures, including 
the plasma membrane and any external encapsulating struc-
tures such as the cell wall and cell envelope, GO:0044424 
Intracellular part is a part of the living contents of a cell. 
In eukaryotes, it includes the nucleus and the cytoplasm. 
As the associated GO terms are related to cell cycle regu-
lation hence, our selected panel of genes is considered to 
be significant for cancer diagnosis. The present study on 
enrichment analysis may provide a basis for the improved 
understanding of the GO enrichment analysis corresponding 
to bladder, colon, kidney, brain, liver, lung, prostate, skin 
and thyroid cancer.
KEGG pathway enrichment analysis
In order to perform the KEGG pathway analysis of the 𝒟ℰg 
genes of our panel, Enrichr (Kuleshov et al. 2016) tool is 
chosen. Enrichr computes the overlap between known 
KEGG pathways and Protein-Protein-Interaction (PPI) 
Table 4  Friedman test ranks of the used optimization algorithms
Tissue ABC ACO DE PCO
BLCA 1 3 2 4
COAD 1 3 2 4
KIRC 1 3 2 4
LGG 1 2 3 4
LIHC 1 3 2 4
LUAD 1 3 2 4
PRAD 1 3 2 4
SKCM 1 3 2 4
THCA 1 3 2 4
Sum of ranks 9 26 19 36
Table 5  Parameters used in the experiments
Method Symbol Value Description
ABC Ncl 50 Colony size
Nitr 50 Number of iterations
aABC 1 Acceleration coefficient
Upper bound
ACO Npar 50 Number of particles
Nitr 50 Number of iterations
 0.5 Intensification factor
zeta 1 Deviation–distance ratio
DE Nip 50 Initial populations
NGr 50 Number of generations
Ngcp 0.8 Cross over probability
PSO Npar 50 Number of particles







IWmax 0.9 Max inertia weight
IWmin 0.4 Min inertia weight
SVM  0.01 SVM  constant
Nexe 50 Number of executions
Genes & Genomics 
1 3
networks for the input set of genes. According to this analy-
sis, lower p-values represent the higher probability of the 
pathway to be enriched with the set of genes. Most signifi-
cant common pathways for each investigated cancer type are 
reported in Table 7.
Among the important pathways, hsa01100: Metabolic 
pathways involved in enzyme-mediated biochemical reac-
tions that lead to the breakdown of natural product small 
molecules within a cell or tissue, hsa01210: 2-Oxocarbox-
ylic acid metabolism composed of 2-oxocarboxylic acids, 
are the most elementary set of metabolites that includes 
pyruvate (2-oxopropanoate), 2-oxobutanoate, oxaloacetate 
and 2-oxoglutarate. Other commonly appearing pathways 
are, hsa00071: Fatty acid degradation, hsa01040: Biosyn-
thesis of unsaturated fatty acids, hsa04068: FoxO sign-
aling pathway, and hsa00020: Citrate cycle (TCA cycle) 
regulates cellular proliferation. In particular hsa04068: 
FoxO signaling pathway actively involved in the regulation 
of the expression of genes in cellular physiological events 
Table 6  Most significant GO terms associated with the optimal signature genes for biological process are obtained through enrichment analysis
GO biological process BLCA COAD KIRC LGG LIHC LUAD PRAD SKCM THCA
GO:0071840 Cellular component organization or biogenesis ✓ ✓ ✓ ✓ ✓
GO:0043482 Cellular pigment accumulation ✓ ✓ ✓ ✓ ✓
GO:0051234 Establishment of localization ✓ ✓ ✓ ✓ ✓
GO:0006996 Organelle organization ✓ ✓ ✓ ✓ ✓
GO:0006082 Organic acid metabolic process ✓ ✓ ✓ ✓ ✓
GO:0043436 Oxoacid metabolic process ✓ ✓ ✓ ✓ ✓
GO:0043476 Pigment accumulation ✓ ✓ ✓ ✓ ✓
GO:0043547 Positive regulation of GTPase activity ✓ ✓ ✓ ✓ ✓
GO:0051130 Positive regulation of cellular component organization ✓ ✓ ✓ ✓ ✓
GO:0044093 Positive regulation of molecular function ✓ ✓ ✓ ✓ ✓
GO:0043087 Regulation of GTPase activity ✓ ✓ ✓ ✓ ✓
GO:0044282 Small molecule catabolic process ✓ ✓ ✓ ✓ ✓
GO:0044281 Small molecule metabolic process ✓ ✓ ✓ ✓ ✓
GO:0006810 Transport ✓ ✓ ✓ ✓ ✓
Table 7  Most common KEGG pathways associated with the optimal signature genes of our cancer panels
KEGG Pathway BLCA COAD KIRC LGG LIHC LUAD PRAD SKCM THCA
hsa01210: 2-Oxocarboxylic acid metabolism ✓ ✓ ✓
hsa01100: Metabolic pathways ✓ ✓ ✓ ✓ ✓
hsa04360: Axon guidance ✓ ✓
hsa01230: Biosynthesis of amino acids ✓ ✓
hsa01040: Biosynthesis of unsaturated fatty acids ✓ ✓ ✓ ✓
hsa00650: Butanoate metabolism ✓
hsa00020: Citrate cycle (TCA cycle) ✓ ✓ ✓
hsa00071: Fatty acid degradation ✓ ✓ ✓
hsa04068: FoxO signaling pathway ✓ ✓
hsa00564: Glycerophospholipid metabolism ✓ ✓
hsa00340: Histidine metabolism ✓ ✓
hsa04142: Lysosome ✓ ✓
hsa00670: One carbon pool by folate ✓ ✓
hsa00770: Pantothenate and CoA biosynthesis ✓ ✓
hsa00120: Primary bile acid biosynthesis ✓ ✓
hsa00640: Propanoate metabolism ✓ ✓
hsa00920: Sulfur metabolism ✓ ✓
hsa00280: Valine, leucine and isoleucine degradation ✓ ✓
hsa00410: beta-Alanine metabolism ✓ ✓
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including apoptosis, cell-cycle control, glucose metabo-
lism, oxidative stress resistance, and longevity.
Conclusions
In this article, we have presented a pipeline to identify 
robust biomarker signatures for several of the most com-
mon cancer types. For this analysis, next-generation 
mRNA sequencing data from TCGA have been used to 
highlight significantly differentially expressed genes 
between healthy and tumor samples. Experimental results 
suggest that informative genes selected by ABC, ACO, 
DE, and PSO algorithms are mostly independent in nature. 
Variation of modeling performance among the optimiza-
tion algorithms leads to the selection of the minutely over-
lapped set of genes irrespective of the datasets. However, 
majority voting of the overlapping sets of genes in differ-
ent runs of the optimization algorithm is considered for 
choosing optimal biomarkers. The subset of overlapping 
genes responsible for highest classification accuracy is 
considered to be the optimal signature by different algo-
rithms. Moreover, classification accuracy is considered as 
the underline objective for optimization and results indi-
cate that all the used optimization algorithms achieve a 
satisfactory classification accuracy. In particular, ABC 
gains a slightly higher accuracy in all the tested datasets.
In conclusion, we can say that the current study identi-
fied robust genes as biomarker signatures and also ana-
lyzed their biological significance. For this analysis, 
pathway enrichment analysis has been used to study the 
overlapping 𝒟ℰg genes with known genes of the KEGG 
pathways. Additionally, GO enrichment analysis also 
added some valuable insight. In particular, most of the 
identified genes are found to be involved in key oncogen-
esis pathways. Therefore, the identified biomarker signa-
tures ( 𝒟ℰg ) in our experiments might be helpful to accu-
rately identify tumors of unknown origin, as well as the 
proposed model itself, may be applied to other clinical 
queries.
Compliance with ethical standards 
Conflicts of interest Shib Sankar Bhowmick, Debotosh Bhattacharjee 
and Luis Rato declare that they have no conflict of interest
Ethical approval All procedures performed in studies involving human 
participants were in accordance with the ethical standards of the insti-
tutional and/or national research committee and with the 1964 Helsinki 
declaration and its later amendments or comparable ethical standards
Informed consent Informed consent was obtained from all individual 
participants included in the study
References
Abu-Mouti FS, El-Hawary M (2011) Optimal distributed generation 
allocation and sizing in distribution systems via artificial bee 
colony algorithm. IEEE Trans Power Deliv 26(4):2090–2101
Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, 
Ryu B, Skinner HG, Goggins M, Jaffee EM (2001) Discovery of 
new markers of cancer through serial analysis of gene expression: 
prostate stem cell antigen is overexpressed in pancreatic adeno-
carcinoma. Cancer Res 61(11):4320–4324
Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, 
Davis AP, Dolinski K, Dwight SS, Eppig JT (2000) Gene ontol-
ogy: tool for the unification of biology. Nat Genet 25(1):25
Boser BE, Guyon IM, Vapnik VN (1992) A training algorithm for opti-
mal margin classifiers. In Proceedings of the fifth annual work-
shop on computational learning theory, Pittsburgh, pp 144–152
Cai H, Chung C, Wong K (2008) Application of differential evolution 
algorithm for transient stability constrained optimal power flow. 
IEEE Trans Power Syst 23(2):719–728
Chandra B, Gupta M (2011) An efficient statistical feature selection 
approach for classification of gene expression data. J Biomed 
Inform 44(4):529–535
Chopra P, Lee J, Kang J, Lee S (2010) Improving cancer classification 
accuracy using gene pairs. PLoS ONE 5(12):e14305
Dorigo M, Stützle T (2003) The ant colony optimization metaheuristic: 
algorithms, applications, and advances. In: Glover F, Kochen-
berger GA (eds) Handbook of metaheuristics. Springer, Boston, 
pp 250–285
Dorigo M, Birattari M, Stützle T (2006) Ant colony optimization. IEEE 
Comput Intell Mag 1(4):28–39
Dorigo M, Birattari M, Blum C, Clerc M, Stützle T, Winfield A (eds) 
(2008) Ant colony optimization and swarm intelligence: 6th Inter-
national conference, ANTS 2008, Brussels, Belgium, September 
22–24, 2008, Proceedings. Theoretical computer science and gen-
eral issues, vol 5217. Springer, Berlin, Heidelberg
Eberhart Shi Y (2001) Particle swarm optimization: developments, 
applications and resources. Proc Evol Comput 1:81–86
Fleming RI, Harbison S (2010) The development of a mRNA multi-
plex RT-PCR assay for the definitive identification of body fluids. 
Forensic Sci Int: Genet 4(4):244–256
Friedman M (1937) The use of ranks to avoid the assumption of 
normality implicit in the analysis of variance. J Am Stat Assoc 
32:675–701
Furey TS, Cristianini N, Duffy N, Bednarski DW, Schummer M, 
Haussler D (2000) Support vector machine classification and 
validation of cancer tissue samples using microarray expression 
data. Bioinformatics 16(10):906–914
Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov 
JP, Coller H, Loh ML, Downing JR, Caligiuri MA (1999) Molecu-
lar classification of cancer: class discovery and class prediction by 
gene expression monitoring. Science 286(5439):531–537
Haas C, Klesser B, Maake C, Bär W, Kratzer A (2009) mRNA profiling 
for body fluid identification by reverse transcription endpoint PCR 
and realtime PCR. Forensic Sci Int: Genet 3(2):80–88
Han M, Liu X (2012) Forward feature selection based on approximate 
Markov blanket. In: International symposium on neural networks, 
Berlin, pp 64–72
Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, 
Staudt LM, Hudson J, Boguski MS (1999) The transcriptional 
program in the response of human fibroblasts to serum. Science 
283(5398):83–87
Juusola J, Ballantyne J (2007) mRNA profiling for body fluid iden-
tification by multiplex quantitative RT-PCR. J Forensic Sci 
52(6):1252–1262
Genes & Genomics 
1 3
Kandaswamy KK, Chou KC, Martinetz T, Möller S, Suganthan P, Srid-
haran S, Pugalenthi G (2011) AFP-Pred: a random forest approach 
for predicting antifreeze proteins from sequence-derived proper-
ties. J Theor Biol 270(1):56–62
Karaboga D, Basturk B (2007) A powerful and efficient algorithm for 
numerical function optimization: artificial bee colony (ABC) algo-
rithm. J Global Optim 39(3):459–471
Karaboga D, Gorkemli B, Ozturk C, Karaboga N (2014) A comprehen-
sive survey: artificial bee colony (ABC) algorithm and applica-
tions. Artif Intell Rev 42(1):21–57
Kennedy J (2011) Particle swarm optimization. In: Sammut C, Webb 
GI (eds) Encyclopedia of machine learning. Springer, New York, 
pp 760–766
Kennedy J, Eberhart R (1995) Particle swarm optimization. Proc IEEE 
Int Conf Neural Netw 4:1942–1948
Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang 
Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A (2016) Enri-
chr: a comprehensive gene set enrichment analysis web server 
2016 update. Nucleic Acids Res 44(W1):W90–W97
Lapointe J, Li C, Higgins JP, Van De Rijn M, Bair E, Montgomery 
K, Ferrari M, Egevad L, Rayford W, Bergerheim U (2004) Gene 
expression profiling identifies clinically relevant subtypes of pros-
tate cancer. Proc Natl Acad Sci 101(3):811–816
Liu H, Liu L, Zhang H (2010) Ensemble gene selection by grouping 
for microarray data classification. J Biomed Inform 43(1):81–87
Liu J, Ranka S, Kahveci T (2008) Classification and feature selec-
tion algorithms for multi-class CGH data. Bioinformatics 
24(13):i86–i95
Liu Q, Sung AH, Chen Z, Liu J, Chen L, Qiao M, Wang Z, Huang X, 
Deng Y (2011) Gene selection and classification for cancer micro-
array data based on machine learning and similarity measures. 
BMC Genom 12(5):S1
Love MI, Huber W, Anders S (2014) Moderated estimation of fold 
change and dispersion for RNA-seq data with DESeq2. Genome 
Biol 15(12):550
Mramor M, Leban G, Demšar J, Zupan B (2007) Visualization-based 
cancer microarray data classification analysis. Bioinformatics 
23(16):2147–2154
Olopade OI, Grushko T (2001) Gene-expression profiles in hereditary 
breast cancer. N Engl J Med 344(26):2028–2029
Ooi C, Tan P (2003) Genetic algorithms applied to multi-class pre-
diction for the analysis of gene expression data. Bioinformatics 
19(1):37–44
Peng Y, Wu Z, Jiang J (2010) A novel feature selection approach for 
biomedical data classification. J Biomed Inform 43(1):15–23
Richard MLL, Harper KA, Craig RL, Onorato AJ, Robertson JM, Don-
fack J (2012) Evaluation of mRNA marker specificity for the iden-
tification of five human body fluids by capillary electrophoresis. 
Forensic Sci Int: Genet 6(4):452–460
Saeys Y, Inza I, Larrañaga P (2007) A review of feature selection tech-
niques in bioinformatics. Bioinformatics 23(19):2507–2517
Shi Y, Eberhart R (1998) A modified particle swarm optimizer. In: 
Proceedings of IEEE international conference on evolutionary 
computation, Anchorage, pp 69–73
Storn R, Price K (1997) Differential evolution-a simple and efficient 
heuristic for global optimization over continuous spaces. J Global 
Optim 11(4):341–359
Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, Jiang J, McLeod 
HL, Atkins D (2004) Gene expression profiles and molecular 
markers to predict recurrence of Dukes’ B colon cancer. J Clin 
Oncol 22(9):1564–1571
Wang Y, Tetko IV, Hall MA, Frank E, Facius A, Mayer KF, Mewes 
HW (2005) Gene selection from microarray data for cancer 
classification-a machine learning approach. Comput Biol Chem 
29(1):37–46
Wobst J, Banemann R, Bastisch I (2011) RNA can do better-an 
improved strategy for RNA-based characterization of differ-
ent body fluids and skin. Forensic Sci Int Genet Suppl Ser 
3(1):e421–e422
Zhang H, Wang H, Dai Z, Ms Chen, Yuan Z (2012) Improving accu-
racy for cancer classification with a new algorithm for genes selec-
tion. BMC Bioinform 13(1):298
